| Species | Dog |
|---|---|
| Origin | United Kingdom |
| Size Category | Large |
| Weight Range | 22.75–34 kg |
|---|---|
| Height Range | 51–66 cm |
| Lifespan | 10–14 years |
| Juvenile Stage Ends | 15 months |
| Senior Age Threshold | 8 years |
| Exercise Needs | High |
|---|---|
| Grooming | High |
| Annual Exam Focus | Cardiac auscultation; Eye exam; Hip palpation; Blood work; Urinalysis; Fecal analysis; Dental exam |
| Routine Care | Monitor for signs of Degenerative Myelopathy (weakening back legs, paralysis), osteoarthritis, vision loss (cataracts/PRA), and cognitive decline. Maintain healthy weight to reduce joint stress. |
| Condition | Onset Stage | Risk | Hereditary | Screening |
|---|---|---|---|---|
| Collie Eye Anomaly | Juvenile | High | No | N/A |
| Dermatomyositis | Juvenile | High | No | N/A |
| Degenerative Myelopathy | Senior | High | No | N/A |
| Collie Eye Anomaly (CEA) | Adult | High | Yes | Recommended |
| Multi-Drug Resistance 1 (MDR1) | Adult | High | Yes | Recommended |
| Progressive Retinal Atrophy rcd2 (PRA-rcd2) | Adult | High | Yes | Recommended |
| Dermatomyositis (DMS) | Adult | High | Yes | Recommended |